A detailed history of Virtu Financial LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Virtu Financial LLC holds 14,387 shares of VRTX stock, worth $6.96 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares
14,387
Holding current value
$6.96 Million
% of portfolio
0.47%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$392.81 - $485.53 $5.65 Million - $6.99 Million
14,387 New
14,387 $6.74 Million
Q4 2022

Feb 15, 2023

BUY
$285.76 - $321.48 $1.85 Million - $2.09 Million
6,486 New
6,486 $1.87 Million
Q4 2021

Feb 17, 2022

SELL
$177.01 - $223.45 $1.22 Million - $1.54 Million
-6,887 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$181.39 - $202.99 $1.25 Million - $1.4 Million
6,887 New
6,887 $1.25 Million
Q3 2020

Dec 11, 2020

SELL
$255.65 - $303.1 $268,432 - $318,255
-1,050 Closed
0 $0
Q2 2020

Aug 07, 2020

SELL
$225.48 - $295.8 $419,843 - $550,779
-1,862 Reduced 63.94%
1,050 $305,000
Q4 2019

Feb 04, 2020

BUY
$166.71 - $223.91 $129,533 - $173,978
777 Added 36.39%
2,912 $638,000
Q3 2019

Nov 20, 2019

BUY
$166.23 - $187.09 $354,901 - $399,437
2,135 New
2,135 $362,000
Q2 2019

Aug 13, 2019

SELL
$164.61 - $190.37 $1.4 Million - $1.62 Million
-8,533 Closed
0 $0
Q1 2019

Apr 12, 2019

BUY
$163.73 - $194.7 $1.4 Million - $1.66 Million
8,533 New
8,533 $1.57 Million
Q2 2018

Jul 30, 2018

SELL
$145.72 - $169.96 $1.19 Million - $1.39 Million
-8,168 Closed
0 $0
Q2 2018

Jul 30, 2018

BUY
$145.72 - $169.96 $954,611 - $1.11 Million
6,551 Added 405.13%
8,168 $1.39 Million
Q1 2018

May 14, 2018

BUY
$151.6 - $177.13 $245,137 - $286,419
1,617 New
1,617 $264,000
Q4 2017

Feb 09, 2018

SELL
$137.28 - $155.55 $2.66 Million - $3.01 Million
-19,372 Closed
0 $0
Q3 2017

Nov 15, 2017

BUY
$148.13 - $162.24 $2.87 Million - $3.14 Million
19,372
19,372 $552,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $124B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.